FDA/CDC
FDA/CDC
CDC concerned about multidrug-resistant Shigella
if clinicians need to use antibiotics to treat patients who have Shigella infections, they should monitor these patients carefully.
FDA/CDC
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
FDA/CDC
FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic
Plazomicin has been recommended by an FDA advisory committee as an added treatment for complicated UTI.
News
FDA: More COPD patients can use triple therapy
The FDA has approved a new indication for a triple therapy for chronic obstructive pulmonary disease patients.
FDA/CDC
FDA approves epinephrine autoinjector for infants and toddlers
A shorter, retractable needle and a lower dose of epinephrine make it ideal for young children.
Latest News
FDA advisors recommend lofexidine for opioid withdrawal
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
FDA/CDC
Gene therapy for hemophilia A gets fast-track review
The FDA has granted breakthrough therapy designation to a gene therapy product aimed at hemophilia A.
FDA/CDC
Imfinzi approved for stage III unresectable NSCLC
Latest News
MMWR: Current flu vaccine does not protect elderly
The influenza vaccine is only about 36% effective this year, preventing infections in just over a third of people who receive it, according to the...
FDA/CDC
FDA approves new combination drug for HIV patients
A new single pill combination drug was approved to treat HIV-1 infections in virologically suppressed adults.